CROI 2015 Program and Abstracts

Poster Listings

Session P-Q10 Poster Session

Poster Hall

794 Renal Tubular Disease and the RelationshipWith Tenofovir and Atazanavir Exposure Lisa Hamzah 1 ; John Booth 2 ; Catherine Horsfield 3 ; Rachael Jones 4 ; Jeremy Levy 5 ; Deborah Williams 6 ; Nadia Khatib 7 ; Rachel Hilton 3 ; John Connolly 2 ; Frank A. Post 8 1 King’s College London, London, United Kingdom; 2 University College London, London, United Kingdom; 3 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom; 4 Chelsea and Westminster Hospital, NHS Foundation Trust, London, United Kingdom; 5 Imperial College London, London, United Kingdom; 6 Brighton and Sussex Hospitals NHS Trust, London, United Kingdom; 7 Heart of England NHS Foundation Trust, Birmingham, United Kingdom; 8 King’s College Hospital NHS Foundation Trust, London, United Kingdom Anton Pozniak 2 ; Jose R Arribas 3 ; Samir K. Gupta 4 ; Frank A. Post 5 ; Anchalee Avihingsanon 6 ; Gordon Crofoot 7 ; Kenneth A. Lichtenstein 8 ; Moti Ramgopal 9 ; Ploenchan Chetchotisakd 10 ; Marshall W. Fordyce 1 1 Gilead Sciences Inc, Foster City, CA, US; 2 Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom; 3 Hospital Universitario La Paz, Madrid, Spain; 4 Indiana University School of Medicine, Indianapolis, IN, US; 5 King’s College Hospital NHS Foundation Trust, London, United Kingdom; 6 HIV-NAT, Thai Red Cross AIDS Research Center and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 7 Crofoot Research, Houston, TX, US; 8 National Jewish Health, Denver, CO, US; 9 Midway Research Center, Ft. Pierce, FL, US; 10 Khon Kaen University, Khon Kaen, Thailand 796 Elevated Nonclassical Monocytes and Urine Fibrotic Markers in HIV Albuminuria Brooks I. Mitchell ; Mary Margeret Byron; Roland C. Ng; Dominic C. Chow; Pichaya O-charoen; Lishomwa C. Ndhlovu; Cecilia M. Shikuma University of Hawaii, Honolulu, HI, US 797 Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study Alison G. Abraham 1 ; Annie Darilay 2 ; Heather McKay 1 ; Joseph B. Margolick 1 ; Michelle M. Estrella 3 ; Frank J. Palella 4 ; Robert Bolan 5 ; Charles R. Rinaldo 6 ; Lisa P. Jacobson 1 1 Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US; 2 AstraZeneca, Gaithersburg, MD, US; 3 Johns Hopkins University School of Medicine, Baltimore, MD, US; 4 Northwestern University, Feinberg School of Medicine, Chicago, IL, US; 5 Los Angeles LGBT Center, Los Angeles, CA, US; 6 University of Pittsburgh, Pittsburgh, PA, US 2:30 pm– 4:00 pm Renal Transplantation: Long-Term Outcomes 798 Risk Factors for Acute Allograft Rejection in HIV Positive Kidney Transplant Recipients Esther N. Gathogo 1 ; Mark Harber 2 ; Sanjay R. Bhagani 2 ; Joanne Baxter 3 ;Vincent Lee 4 ; Jeremy Levy 5 ; Rachael Jones 6 ; Rachel Hilton 7 ; Graham Davies 1 ; Frank A. Post 1 1 King’s College London, London, United Kingdom; 2 Royal Free London NHS Foundation Trust, London, United Kingdom; 3 North Manchester General Hospital, Manchester, United Kingdom; 4 Central Manchester University Hospitals, Manchester, United Kingdom; 5 Imperial College Healthcare NHS Trust, London, United Kingdom; 6 Chelsea and Westminster Hospital, NHS Foundation Trust, London, United Kingdom; 7 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom 799 Survival in HIV-Positive Transplant Recipients Compared to Matched Registry Controls Michelle E. Roland 1 ; Burc Barin 2 ; Shirish Huprikar 3 ; Michael Wong 4 ; Emily Blumberg 5 ; David Simon 6 ; Margaret Ragni 7 ; Don Stablein 2 ; Peter Stock 1 HIV-TR StudyTeam 1 University of California San Francisco, San Francisco, CA, US; 2 EMMES Corporation, Rockville, MD, US; 3 Mount Sinai School of Medicine, New York, NY, US; 4 Beth Israel Deaconess Medical Center, Boston, MA, US; 5 University of Pennsylvania, Philadephia, PA, US; 6 Rush University Medical Center, Chicago, IL, US; 7 University of Pittsburgh, Pittsburgh, PA, US Session P-Q9 Poster Session 795 Safety of Tenofovir Alafenamide in Renal Impairment

2:30 pm– 4:00 pm Pulmonary Disease 800 Risk Factors for Airflow Obstruction Among HIV+ Individuals in Nairobi, Kenya Engi F. Attia 1 ; Elizabeth Maleche-Obimbo 2 ; NellyYatich 1 ; Lillian Ndukwe 3 ; Julia Njoroge 3 ; Sameh Sakr 3 ; Neveen El Antouny 3 ; Fr. Mena Attwa 3 ; Kristina Crothers 1 ; Michael Chung 1 1 University of Washington, Seattle, WA, US; 2 University of Nairobi, Nairobi, Kenya; 3 Coptic Hope Center for Infectious Diseases, Nairobi, Kenya 801 Pulmonary Complications of HIV-1 in Youth: The PHACS AMP Study William T. Shearer 1 ; Erin Leister 2 ; George Siberry 3 ; Denise L. Jacobson 2 ; Russell B.Van Dyke 4 ; Hannah H. Peavy 5 ; Suzanne Siminski 6 ; Meyer Kattan 7 ; Laurie Butler 6 ; Andrew Colin 8 1 Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, US; 2 Harvard School of Public Health, Boston, MA, US; 3 National Institutes of Health (NIH), Bethesda, MD, US; 4 Tulane University Health Sciences Center, New Orleans, LA, US; 5 National Heart, Lung, and Blood Institute, Bethesda, MD, US; 6 Frontier Science and Technology Research Foundation, Amherst, NY, US; 7 Columbia University Medical Center, New York, NY, US; 8 University of Miami Health System Batchelor Research Institute, Miami, FL, US 802 Distinct Airway Methylation and Gene Expression Profiles in HIV- Associated COPD Janice M. Leung 1 ; EmilyVucic 2 ; Joseph C. Liu 1 ; David Ngan 1 ;Tawimas Shaipanich 3 ; Julio Montaner 4 ; Stephen Lam 2 ; Don Sin 1 ;Wan Lam 2 ; S. F. Paul Man 1 1 Centre for Heart Lung Innovation, Vancouver, Canada; 2 BC Cancer Research Center, Vancouver, Canada; 3 St. Paul’s Hospital, Vancouver, Canada; 4 BC Centre for Excellence in HIV/AIDS, Vancouver, Canada 2:30 pm– 4:00 pm Body Composition and Risk Factors for Abnormalities 803 Altered Body Composition and Inflammation in HIV InfectionWith Type 2 Diabetes Malene Hove ; Julie Abildgaard; Julie C. Gaardbo; AllanVaag; Jan Gerstoft; Bente Klarlund Pedersen; Birgitte Lindegaard; Susanne D. Poulsen Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark 804 Alcohol, Substance Use, and Smoking Associations With Lipoatrophy and Lipohypertrophy Marisela Noorhasan 1 ; Daniel R. Drozd 1 ; Aaron Blashill 2 ; Greer Burkholder 3 ; Karen Cropsey 3 ; MatthewMimiaga 2 ; Katerina Christopoulos 4 ; Carl Grunfeld 4 ; Heidi M. Crane 1 Centers for AIDS Research Network of Integrated Clinical Systems 1 University of Washington, Seattle, WA, US; 2 Harvard Medical School, Boston, MA, US; 3 University of Alabama at Birmingham, Birmingham, AL, US; 4 University of California San Francisco, San Francisco, CA, US 2:30 pm– 4:00 pm Complications: Liver DiseaseWithout Viral Hepatitis 805 Antiretroviral Drugs AssociatedWith Chronic ALT Elevations in Persons Without HCV and HBV Infection Helen Kovari 1 ; Caroline Sabin 2 ; Bruno Ledergerber 1 ; Lene Ryom 3 ; Antonella d’Arminio Monforte 4 ; Matthew G. Law 5 ; Stéphane DeWit 6 ; Andrew N. Phillips 2 ; Jens D. Lundgren 3 ; RainerWeber 1 on behalf of the D:A:D Study Group 1 University Hospital Zurich, Zurich, Switzerland; 2 University College London, London, United Kingdom; 3 University of Copenhagen, Copenhagen, Denmark; 4 University of Milan, Milan, Italy; 5 University of New South Wales, Sydney, Australia; 6 St Pierre University Hospital, Brussels, Belgium Session P-Q11 Poster Session Poster Hall Session P-Q12 Poster Session Poster Hall

Poster Listings

Poster Hall

62

CROI 2015